首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Biological Evaluation of Novel Synthesized 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives
【24h】

Biological Evaluation of Novel Synthesized 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives

机译:新型合成的2,5-二取代-1,3,4-恶二唑衍生物的生物评价

获取原文
           

摘要

Synthesis of a series of various 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives (7a-7v) have been done previously. These novel synthesized derivatives (7a-7v) have been tested for their antibacterial activity against Gram +ve S. aureus and Gram -ve E. Coli bacterias by broth dilution method. A comparative study has been done for all derivatives. Based on the visual turbidity, the MIC of the evaluated molecules has been studied, the evaluation concentration was used single therefore, the exact MIC could not determined and results are represented in less than and more than based on growth of microorganism. To get more exact MIC of the tested molecules need to be evaluated at low concentration. Further testing for all compounds at lower concentrations is required to compare their activity with standard Streptomycin at its MIC to get exact MIC the synthesized compounds. Previously novel synthesized derivatives are; 2-(phenoxymethyl)-5-phenyl-1, 3, 4-oxadiazole (7a), 4-(5-(phenoxymethyl)-1, 3, 4-oxadiazol-2-yl)aniline (7b), 3-(5-(phenoxymethyl)-1, 3, 4-oxadiazol-2-yl) aniline (7c), 2-(5-(phenoxymethyl)-1, 3, 4-oxadiazol-2-yl)phenol (7d), 2, 4-dinitro-6-(5-(phenoxymethyl)-1, 3, 4-oxadiazol-2-yl)phenol (7e), 2-(4-(methylthio)benzyl)-5-(phenoxymethyl)-1,3,4-oxadiazole (7f), 2-((2, 4-dichlorophenoxy) methyl)-5-phenyl-1,3,4-oxadiazole (7g), 4-(5-((2, 4-dichlorophenoxy) methyl)-1,3,4-oxadiazol-2-yl)aniline (7h), 3-(5-((2, 4-dichlorophenoxy) methyl)-1,3,4-oxadiazol-2-yl)aniline (7i), 2-(5-((2, 4-dichlorophenoxy) methyl)-1, 3, 4-oxadiazol-2-yl)phenol (7j), 2-(5-((2, 4-dichlorophenoxy) methyl)-1,3,4-oxadiazol-2-yl)-4,6-dinitrophenol (7k), 2-((2,4-dichlorophenoxy) methyl)-5-(4-(methylthio)benzyl)-1,3,4-oxadiazole (7l), (Z)-2-((2, 4-dichlorophenoxy) methyl)-5-styryl-1,3,4-oxadiazole (7m), (S)-4-(2-(5-((2,4-dichlorophenoxy) methyl)-1, 3, 4-oxadiazol-2-yl)propyl)phenol (7n), 2-((4-nitrophenoxy) methyl)-5-phenyl-1, 3, 4-oxadiazole (7o), 4-(5-((4-nitrophenoxy)methyl)-1,3,4-oxadiazol-2-yl)aniline (7p), 3-(5-((4-nitrophenoxy)methyl)-1,3,4-oxadiazol-2-yl)aniline (7q), 2-(5-((4-nitrophenoxy)methyl)-1,3,4-oxadiazol-2-yl)phenol (7r), 2, 4-dinitro-6-(5-((4-nitrophenoxy)methyl)-1,3,4-oxadiazol-2-yl)phenol (7s), 2-(4-(methylthio) benzyl)-5-((4-nitrophenoxy) methyl)-1,3,4-oxadiazole (7t), (Z)-2-((4-nitrophenoxy)methyl)-5-styryl-1,3,4-oxadiazole (7u) and 5-((2, 4-dichlorophenoxy) methyl)-1,3,4-oxadiazole-2-thiol (7v).
机译:先前已经完成了一系列各种2,5-二取代-1,3,4-恶二唑衍生物(7a-7v)的合成。已通过肉汤稀释法测试了这些新型合成衍生物(7a-7v)对革兰氏+金黄色葡萄球菌和革兰氏-VE大肠杆菌的抗菌活性。已对所有衍生物进行了比较研究。基于视觉浊度,对被评估分子的MIC进行了研究,评估浓度仅使用一次,因此无法确定确切的MIC,且结果表示的结果小于或大于基于​​微生物的生长。为了获得更准确的被测分子MIC,需要在低浓度下进行评估。需要对所有浓度较低的化合物进行进一步测试,以将其活性与标准链霉素在其MIC处的活性进行比较,以准确获得所合成化合物的MIC。先前新颖的合成衍生物是; 2-(苯氧基甲基)-5-苯基-1,3,4-恶二唑(7a),4-(5-(苯氧基甲基)-1,3,4-恶二唑-2-基)苯胺(7b),3-( 5-(苯氧甲基)-1,3,4-恶二唑-2-基)苯胺(7c),2-(5-(苯氧甲基)-1,3,4-恶二唑-2-基)苯酚(7d),2 ,4-二硝基-6-(5-(苯氧基甲基)-1,3,4-恶二唑-2-基)苯酚(7e),2-(4-(甲硫基)苄基)-5-(苯氧基甲基)-1, 3,4-恶二唑(7f),2-((2,4-二氯苯氧基)甲基)-5-苯基-1,3,4-恶二唑(7g),4-(5-((2,4-二氯苯氧基)甲基)-1,3,4-恶二唑-2-基)苯胺(7h),3-(5-((2,4-二氯苯氧基)甲基)-1,3,4-恶二唑-2-基)苯胺( 7i),2-(5-(((2,4-dichlorophenoxy)methyl)-1,3,4-oxadiazol-2-yl)phenol(7j),2-(5-((2,4-dichlorophenoxy)methyl )-1,3,4-恶二唑-2-基)-4,6-二硝基苯酚(7k),2-((2,4-二氯苯氧基)甲基)-5-(4-(甲硫基)苄基)-1, 3,4-恶二唑(7l),(Z)-2-(((2,4-二氯苯氧基)甲基)-5-苯乙烯基-1,3,4-恶二唑(7m),(S)-4-(2- (5-(((2,4-二氯苯氧基)甲基)-1,3,4-恶二唑-2-基)丙基)苯酚(7n),2-((4-硝基苯氧基)甲基)-5-苯1-1,3,4-恶二唑(7o),4-(5-((4-硝基苯氧基)甲基)-1,3,4-恶二唑-2-基)苯胺(7p),3-(5-( (4-硝基苯氧基)甲基)-1,3,4-恶二唑-2-基)苯胺(7q),2-(5-((4-硝基苯氧基)甲基)-1,3,4-恶二唑-2-基)酚(7r),2,4-二硝基-6-(5-(((4-硝基苯氧基)甲基)-1,3,4-恶二唑-2-基)酚(7s),2-(4-(甲硫基) )苄基)-5-((4-硝基苯氧基)甲基)-1,3,4-恶二唑(7t),(Z)-2-((4-硝基苯氧基)甲基)-5-苯乙烯基-1,3,4 -恶二唑(7u)和5-((2,4-二氯苯氧基)甲基)-1,3,4-恶二唑-2-硫醇(7v)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号